![Nancy Valente](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nancy Valente
Direktor/Vorstandsmitglied bei
Myovant Sciences GmbH
Vermögen: 350 757 $ am 31.05.2026
Profil
Nancy Valente currently works at Myovant Sciences GmbH, as Director.
Dr. Valente also formerly worked at Myovant Sciences Ltd., as Independent Director from 2021 to 2023, Immatics NV, as Non-Executive Director from 2022 to 2023, Genentech, Inc., as Vice President-Global Hematology Development, Roche Pharmaceuticals, Inc., as SVP & Lead-Global Product Development from 2019 to 2021, Xencor, Inc., as Chief Development Officer & Executive VP from 2023 to 2025, and Anosys, Inc., as Vice President-Clinical Development from 1998 to 2001.
Dr. Valente received her undergraduate degree and doctorate degree from the University of Missouri.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
XENCOR, INC. 0,04 % | 28.02.2026 | 29.525 ( 0,04 % ) | 350 757 $ | 31.05.2026 |
Aktive Positionen von Nancy Valente
| Unternehmen | Position | Beginn |
|---|---|---|
Myovant Sciences GmbH
 Myovant Sciences GmbH BiotechnologyHealth Technology Engages in development and marketing of biopharmaceutical products | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Nancy Valente
| Unternehmen | Position | Ende |
|---|---|---|
| XENCOR, INC. | Direktor/Vorstandsmitglied | 01.05.2023 |
| IMMATICS N.V. | Direktor/Vorstandsmitglied | 12.05.2023 |
| MYOVANT SCIENCES LTD. | Direktor/Vorstandsmitglied | 10.03.2023 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | 01.06.2021 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Ausbildung von Nancy Valente
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
91
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
University of Missouri
 University of Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anosys, Inc.
 Anosys, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines infectious diseases and cancer | Health Technology |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides women's health and prostate cancer solutions | Health Technology |
Myovant Sciences GmbH
Myovant Sciences GmbH BiotechnologyHealth Technology Engages in development and marketing of biopharmaceutical products | Health Technology |
Immatics NV
 Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
